ArriVent BioPharma, Inc.

SEC 4 · Filed

0001104659-26-010477Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 2, 2026

Grant, award or other acquisition by Lutzker Stuart

Security
Stock Option (right to buy)
Code
A
Shares
150,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-02",
  "direction": "A",
  "exercise_price": "22.67",
  "expiration": "2036-02-02",
  "footnotes": {
    "F1": "The shares underlying this option vest as to 25% on February 2, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person\u0027s continued service through the applicable vesting date."
  },
  "owners": [
    {
      "cik": "0002009257",
      "name": "Lutzker Stuart",
      "roles": [
        "director",
        "officer"
      ],
      "title": "President of R\u0026D"
    }
  ],
  "ownership": "D",
  "post_shares": "150000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "150000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "150000"
}